Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Your research will be conducted at the Department of Urology, the Department of Pathology and Clinical Bioinformatics at Erasmus MC in Rotterdam, and in collaboration with the Computational
-
, bioinformatics, and statistics, both within and outside UMC Utrecht (including the Dutch Center for RNA Therapeutics and Charles River Laboratories). Informal yet close collaboration with fellow PhD candidates
-
patients. The candidate will work closely with a multidisciplinary team consisting of colleagues from biomedical sciences, medicine, bioinformatics, and statistics, both within and outside UMC Utrecht
-
Institute of Chemistry are looking for a PhD candidate to pursue research on the development of host-directed therapeutics for mycobacterial infections. Mycobacterial infections are among the top 10 cause
-
Immonuprecipitation (ChIP); Genome editing, e.g. to (degron) tag proteins of interest; Bioinformatic analysis of generated sequencing data. During your PhD, you will learn about the field of gene regulation, expand our
-
to treat infectious disease. Mycobacterial infections are among the top 10 cause of death globally. Although cases of tuberculosis are typically decreasing because of concerted global efforts, respiratory
-
and outside the project. Required educational backgroud A MSc degree in technical medicine, bioengineering, biomedical science, immunology, biotechnology, (bio)analytical chemisty, bioinformatics
-
the Faculty of Science of Leiden University. We offer courses at the Bachelor and Master of Science level in Artificial Intelligence, Computer Science, ICT in Business, Media Technology, and Bioinformatics
-
, Media Technology, and Bioinformatics. According to an independent research visitation, we are one of the foremost computer science departments of the Netherlands. We strive for excellence in a caring
-
immunometabolism. Immune dysregulation contributes to many human diseases, including cancer, cardiovascular disease, chronic infections, and neurodegeneration. Developing drugs that restore immune function could